Pan-cancer analyses identify oncogenic drivers, expression signatures, and therapeutic vulnerabilities in RHO GTPase pathway genes
Rubén Fernández, L. Francisco Lorenzo-Martín, Víctor Quesada, Xosé R. Bustelo · 2025
Read Pan-cancer analyses identify oncogenic drivers, expression signatures, and therapeutic vulnerabilities in RHO GTPase pathway genes by Rubén Fernández, L. Francisco Lorenzo-Martín, Víctor Quesada, Xosé R. Bustelo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753894.txt.
Description
Rubén Fernández and co-authors present a 2025 study of a gene family tied to cancer cell movement. The RHO family helps run the cell skeleton and steers growth, spread, and survival. Past work looked at these genes one tumor at a time. The team scanned all cancers at once for changes in 484 genes of the pathway and its close partners.
The scan drew on over 10,000 tumor samples across 33 cancer types. It also used screens that knock out genes in over 1,000 cancer cell lines. The team found favored mutations in both known and new pathway genes. Many genes showed odd levels in tumors, some against their known roles. Groups of genes switched on as a team, tied to traits such as cell movement. The map flags drug targets hiding in a well-known pathway.
Catalog record
| CREATOR | Rubén Fernández, L. Francisco Lorenzo-Martín, Víctor Quesada, Xosé R. Bustelo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |